While this may seem inconsistent with the earlier mention of ACE2 downregulation in CF patients (Section 5.2), the variation in ACE2 expression can be explained by differences in measurement methods (mRNA vs. protein), post-transcriptional regulation, and model-specific factors such as CFTR mutation type and infection timing. Here, ACE2 is linked to cystic fibrosis.